Concepedia
Statistics
Publications
35
Citations
3.4K
H-Index
26
Active since
2000
Affiliations
Amgen (United States)(Current)
Université de Montréal
Massachusetts Institute of Technology
Ryan P. Wurz is an author at Amgen (United States) specializing in pharmacology, medicine, and drug discovery.
Top concepts
PharmacologyMedicineDrug DiscoveryMedicinal ChemistryBiochemistryNatural SciencesPharmacotherapyChemistryOrganic ChemistryTumor Biology
Publications per year
2000–2023
Discovery of a Covalent Inhibitor of KRAS<sup>G12C</sup> (AMG 510) for the Treatment of Solid Tumors
Brian A. Lanman, Jennifer R. Allen, John G. Allen et al. · Journal of Medicinal Chemistry · 2019 · 677 citations · Full text
Drug Target, Solid Tumors, Molecular Biology +20
Catalytic Asymmetric Synthesis of Piperidine Derivatives through the [4 + 2] Annulation of Imines with Allenes
Ryan P. Wurz, Gregory C. Fu · Journal of the American Chemical Society · 2005 · 375 citations
Asymmetric Catalysis, Chemical Engineering, Catalytic Asymmetric Synthesis +14
Photoinduced, Copper-Catalyzed Decarboxylative C–N Coupling to Generate Protected Amines: An Alternative to the Curtius Rearrangement
Wei Zhao, Ryan P. Wurz, Jonas C. Peters et al. · Journal of the American Chemical Society · 2017 · 317 citations · Full text
TBK1 Directly Engages Akt/PKB Survival Signaling to Support Oncogenic Transformation
Yi-Hung Ou, Michael J. Torres, Rosalyn Ram et al. · Molecular Cell · 2011 · 227 citations · Full text
Signal Transduction, Signaling Pathway, Cell Regulation +7
Doubly Activated Cyclopropanes as Synthetic Precursors for the Preparation of 4-Nitro- and 4-Cyano-dihydropyrroles and Pyrroles
Ryan P. Wurz, André B. Charette · Organic Letters · 2005 · 210 citations
Situ-generated Phenyliodonium Ylides, Chemical Engineering, 1-Cyano-cyclopropyl Ketones +15
1–5 of 35